These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31563809)

  • 41. Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa.
    Rodríguez-Sevilla G; Crabbé A; García-Coca M; Aguilera-Correa JJ; Esteban J; Pérez-Jorge C
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
    Patel KK; Surekha DB; Tripathi M; Anjum MM; Muthu MS; Tilak R; Agrawal AK; Singh S
    Mol Pharm; 2019 Sep; 16(9):3916-3925. PubMed ID: 31318574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
    Dhal C; Mishra R
    Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
    Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.
    Barros CHN; Hiebner DW; Fulaz S; Vitale S; Quinn L; Casey E
    J Nanobiotechnology; 2021 Apr; 19(1):104. PubMed ID: 33849570
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Pinto RM; Monteiro C; Costa Lima SA; Casal S; Van Dijck P; Martins MCL; Nunes C; Reis S
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42329-42343. PubMed ID: 34464076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.
    Hengzhuang W; Høiby N; Ciofu O
    Methods Mol Biol; 2014; 1147():239-54. PubMed ID: 24664838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells.
    Cheow WS; Chang MW; Hadinoto K
    J Biomed Nanotechnol; 2010 Aug; 6(4):391-403. PubMed ID: 21323113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities.
    Alhariri M; Majrashi MA; Bahkali AH; Almajed FS; Azghani AO; Khiyami MA; Alyamani EJ; Aljohani SM; Halwani MA
    Int J Nanomedicine; 2017; 12():6949-6961. PubMed ID: 29075113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains.
    Machul A; Mikołajczyk D; Regiel-Futyra A; Heczko PB; Strus M; Arruebo M; Stochel G; Kyzioł A
    J Biomater Appl; 2015 Sep; 30(3):269-78. PubMed ID: 25855683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 53. Externally controlled triggered-release of drug from PLGA micro and nanoparticles.
    Hua X; Tan S; Bandara HM; Fu Y; Liu S; Smyth HD
    PLoS One; 2014; 9(12):e114271. PubMed ID: 25479357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Melaleuca alternifolia oil nanoparticles on aspects of Pseudomonas aeruginosa biofilm.
    Comin VM; Lopes LQ; Quatrin PM; de Souza ME; Bonez PC; Pintos FG; Raffin RP; Vaucher Rde A; Martinez DS; Santos RC
    Microb Pathog; 2016 Apr; 93():120-5. PubMed ID: 26821356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.
    Takahashi C; Hattori Y; Yagi S; Murai T; Takai C; Ogawa N; Tanemura M; Fuji M; Kawashima Y; Yamamoto H
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():78-83. PubMed ID: 30678968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 58. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections.
    Noreddin AM; Elkhatib WF
    J Infect Public Health; 2009; 2(3):120-8. PubMed ID: 20701871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
    Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M
    J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.